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bert, Wim Sluiter, Patricia K. Donahoe, Johan C. de 
Jongste, Jay J. Schnitzer, and Dick Tibboel. Prenatal 
hormones alter antioxidant enzymes and lung histology in 
rats with congenital diaphragmatic hernia. Am. J. PhysioZ. 
272 (Lung CeZZ. MOL. PhysioZ. 16): L1059-LlO65, 1997.- 
Prenatal administration of dexamethasone (Dex) and thyro- 
tropin-releasing hormone (TRH) synergistically enhances 
lung maturity, but TRH suppresses the antioxidant enzyme 
activity. Prenatal hormonal therapy improves alveolar surfac- 
tant content and lung compliance in rats with congenital 
diaphragmatic hernia (CDH). In full term neonatal rats with 
CDH we studied the effects of prenatal Dex or Dex + TRH on 
antioxidant enzyme activity at birth, on survival, and on lung 
morphometry after 4 h of ventilation with 100% 02. CDH was 
induced by administration of 2,4-dichlorophenyl-p-nitro- 
phenylether (Nitrofen) on gestational day 10. Dex + TRH- 
treated CDH rats had lower activity of glutathione reductase 
after birth than did sham-treated CDH pups. Dex-treated 
and sham-treated pups had similar antioxidant enzyme 
activity. Hormonal treatment did not change survival during 
ventilation. The average airspace volume increased in Dex- 
treated CDH pups after ventilation, with a small synergistic 
effect after addition of TRH. On the basis of our findings, we 
speculate that prenatal administration of Dex is the best 
choice to improve lung maturity and airspace volume in CDH 
patients. 
glucocorticosteroids; thyroid-releasing hormone; artificial ven- 
tilation; morphometry; newborn animal 
THE EFFECTS OF PRENATAL application of corticosteroids 
and thyroid hormones on lung maturity and on the 
antioxidant enzyme system have been studied experi- 
mentally in several animal models (7, 9, 13, 18). It 
appeared that dexamethasone (Dex) and thyroid hor- 
I mone have a synergistic effect on the development of 
the surfactant system but have a negative effect on 
antioxidant enzyme activity (18). Clinically, the effects 
, of prenatal hormonal therapy have been studied with 
respect to mortality and morbidity in preterm children 
(1, 2). Administration of glucocorticoids to women at 
risk of preterm delivery was recommended (2), but the 
’ addition of thyrotropin-releasing hormone (TRH) to 
glucocorticoids is still debated because maternal and 
perinatal risks have been reported (1). 
r Children with congenital diaphragmatic hernia 
(CDH) have abnormal morphological development of 
the lungs (16), which may lead to respiratory insuffi- 
ciency shortly after birth. Several publications suggest 
that in CDH the lungs are biochemically immature (12, 
16), although normal lecithin-to-sphingomyelin ratios 
in amniotic fluid of CDH patients have been reported 
(27). More recent data suggest, however, that infants 
with CDH do have surfactant deficiency (15). Indica- 
tions for lung immaturity in CDH have been found in 
several animal studies of CDH using sheep and rats 
(10,25). 
In our previously described rat model of CDH (28) 
and in lambs with prenatal CDH, glucocorticoids im- 
proved the biochemical and morphological immaturity 
at birth and the compliance of the lungs (14,21,24,26). 
Prenatal administration of Dex in combination with 
TRH also improved lung compliance (14) and showed 
the best effects on disaturated phosphatidylcholine and 
glycogen content of the lungs in rat pups with CDH at 
birth (26). In this CDH model, the effects of prenatal 
application of glucocorticoids and TRH on the antioxi- 
dant enzyme system and on the tolerance to hyperoxia 
and barotrauma have not been studied yet. We hypoth- 
esized that prenatal glucocorticoids would improve 
survival and lung morphology after artificial ventila- 
tion with 100% 02, with synergistic effects on lung 
morphology after the combination of glucocorticoids 
and TRH. Moreover, we hypothesized that the combina- 
tion of Dex and TRH might have a negative effect on 
antioxidant enzyme activity. Therefore, in newborn 
rats with CDH, we evaluated the effects of prenatal 
hormonal therapy with Dex or the combination of Dex 
and TRH on the antioxidant enzyme activity at birth 
and on survival and lung morphometry after a short 
period of hyperoxic artificial ventilation. 
MATERIALS AND METHODS 
Animal model. Female Sprague-Dawley rats (Harlan Olac), 
weighing -250 g, were mated during 1 h (day 0 of gestation). 
Ten of seventeen pregnant rats received 100 mg of 2,4-dichloro- 
phenyl-p-nitrophenylether (Nitrofen; Rohm Haas, Philadel- 
phia, PA) on day 10 of gestation, as described before (28); the 
remaining seven rats provided control pups. Nitrofen results 
in a diaphragmatic defect with lung hypoplasia in up to 80% 
of the offspring (28). Food and water were supplied ad libitum 
during the whole period of pregnancy. At gestational day 22 
(term = 22-23 d ays) the dam was anesthetized by inhalation 
of diethylether, and a caesarean section was performed. The 
1040-0605/97 $5.00 Copyright o 1997 the American Physiological Society LlO59 
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L1060 PRENATAL HORMONAL MODULATION IN CDH 
mean numbers of rat pups in the Nitrofen-exposed and 
control litters were 13.1 t 0.8 and 13.6 t 0.8, respectively. 
All animal experiments were performed after approval of 
the Animal Care and Use Committee of the Erasmus Univer- 
sity, Rotterdam, The Netherlands. 
Prenatal hormonal therapy. Six different study groups 
were created: sham-treated CDH rats (2 litters) and controls 
(2 litters), Dex-treated CDH rats (5 litters) and controls (2 
litters), and Dex + TRH-treated CDH rats (3 litters) and 
controls (3 litters). 
On days 19 and 20, i.e. 72 and 48 h before delivery, 
pregnant dams received 0.25 mgikg Dex sodium-phosphate in 
0.2 ml ip of saline, the lowest dose that is known to result in 
biochemical and morphometrical improvement with the least 
effects on somatic and pulmonary growth (24). TRH (Calbio- 
them, La Jolla, CA) was administered intraperitoneally to 
the pregnant dams as a loading dose (25 pg/kg in 0.5 ml of 
saline) and by an implanted osmotic minipump (Alzet pump, 
model 1003D; Alza, Palo Alto, CA) through which TRH was 
continuously administered intraperitoneally in a dose of 100 
pg. kg-l l day-l (18). This pump was implanted intraperitone- 
ally on day 20 of gestation under short anesthesia with 
diethylether through a small midline incision using a sterile 
technique and provided TRH continuously for 48 h. Sham 
treatment was given using intraperitoneal injections of saline 
and implantation of an osmotic pump filled with saline. 
Measurement of antioxidant enzyme activity. Five to eight 
of the newborn rats per group were killed for antioxidant 
enzyme measurement directly after birth. The presence and 
size of the diaphragmatic defects were assessed in Nitrofen- 
exposed rats. To obtain a homogeneous study group, Nitrofen- 
exposed rat pups without CDH (n = 8) were excluded. The 
numbers of rat pups studied per group were n = 5 in 
sham-treated CDH rat pups and controls, n = 6 and n = 5 in 
Dex-treated CDH pups and controls, respectively, and n = 5 
in Dex + TRH-treated CDH pups and controls. 
After removal of the heart-lung block, the lungs were 
stripped of nonpulmonary tissue, weighed, frozen with liquid 
nitrogen, and stored at -70°C until further processing as 
previously described (23). All biochemical analyses were 
performed on lungs from separate rat pups. After thawing, 
the lungs were diluted 1:15 (wt/vol) in ice-cold phosphate- 
buffered saline and homogenized with a Brinkmann Polytron 
(Brinkmann Instruments, Westbury, NY) for 15 s at maxi- 
mum speed. Next, the suspension was sonicated for 10 s on 
ice. In this crude suspension, concentrations of protein and 
DNA were estimated as described previously (23). To deter- 
mine antioxidant enzyme, the crude suspensions were centri- 
fuged at 20,000 g for 30 min, and the pellets were discarded. 
The activities of glutathione peroxidase and catalase were 
measured as described before (23). Glutathione reductase 
activity was determined as described by Goldberg and Spooner 
(11). Superoxide dismutase (SOD) activity was determined by 
using the SOD-525 method (R & D Systems, Abingdon, UK). 
Correction for blood contamination was performed as fol- 
lows. From three different control litters, the red blood cells of 
three to five rat pups were collected for measurement of 
hemoglobin (22) and antioxidant enzyme activity. The antioxi- 
dant enzyme activity per milligram of hemoglobin was thus 
determined. The hemoglobin concentration was also mea- 
sured in the lung suspensions. The antioxidant enzyme 
activity resulting from blood contamination was calculated 
and subtracted from the total antioxidant enzyme activity in 
the lung suspensions. To facilitate comparison and to exclude 
differences merely based on differences in lung weight, the 
activities of glutathione reductase, glutathione peroxidase, 
catalase, and SOD were all expressed as units per milligram 
of lung DNA. 
Artificial ventilation. After birth, the newborns were 
weighed, anesthetized with 30 mg/kg ip pentobarbital so- 
dium, paralyzed with 0.08 mg/kg ip pancuronium bromide, 
intubated with a 24-gauge intravenous catheter (Neoflon; 
Viggo-Spectramed, Helsingborg, Sweden) with an atraumatic 
stent, transferred to a multichambered body plethysmograph 
heated to 37°C and connected in the supine position to a 
modified Servo 900B ventilator (Siemens-Elema, Solna, Swe- 
den). Pressure-controlled ventilation was started using the 
following respirator settings: peak inspiratory pressure (PIP), 
25 cmHsO; positive end expiratory pressure, 3 cmHa0; fre- 
quency, 40 cycles/min; fraction of inspired 02 concentration, 
1.0; and inspiratory-to-expiratory ratio, 1:2. A previously 
performed study revealed that opening pressures of 25 cmHzO 
were needed to obtain a good lung aeration pattern but that 
continuous ventilation with this peak pressure resulted in a 
high incidence of pneumothorax (Tibboel, unpublished data). 
Therefore, PIP was reduced to 17 cmHZO after 30 min. The 
incidence of pneumothorax, absent heart action, or other 
complications related to insufficient ventilation were re- 
corded in ventilated rat pups. In case of death the lungs were 
processed immediately for histological examination. After 4 h, 
the surviving pups were killed. Autopsy revealed whether a 
diaphragmatic defect in Nitrofen-exposed pups was present. 
HistologicaL studies. The trachea was cannulated, the 
thorax was opened, and the lungs were inflated at a constant 
pressure of 20 cmH20 with 10% Formalin as described by 
Burri et al. (6). The distended lungs were removed from the 
thoracic cavity, and the trachea was ligated to maintain lung 
inflation during fixation for 24 h. After 24 h, the lung volume 
(V,) was measured by the volume displacement method (20). 
The fixed tissue was dehydrated in a graded alcohol series, 
embedded in paraffin, and cut in l-cm slices in the parasagit- 
tal plane. Random l-cm2 specimens were taken from the lung 
for histological examination; 8-pm coronal sections were cut 
and stained with hematoxylin and eosin. 
Morphometry was performed using techniques adapted 
from Weibel (29) and Emery and Mithal (8). Histological 
sections were examined with the aid of a Nikon microscope 
(Microphot-FXA; Nikon, Melville, NY) at X 100 magnification 
via a charge-coupled device color video camera (DXC-151; 
Sony, Park Ridge, NJ) linked to a Sony color television 
monitor overlaid with a 42-point equidistant counting grid 
calibrated with an individual probe length line (2) where 2 = 
83 pm. Lungs from CDH rats (sham, n = 7; Dex-CDH, n = 9; 
Dex + TRH-CDH, n = 5) in each treatment group were 
subsequently evaluated. The complete coronal sectional area 
of each lung was analyzed using three different histological 
sections (6-10 fields per lung per slide) for each animal. Each 
coronal sectional area encompassed 18-30 fields per lung; the 
right and left lungs were studied separately, and these data 
were later combined because there were no significant differ- 
ences between both lungs. 
Volume fractions were established by counting test points 
falling on airspaces (volume fraction of airspaces, Vva& 
alveolar septa (volume fraction of airspace walls), airways 
(volume fraction of airways), and non-gas-exchanging ele- 
ments, i.e., all other structures (volume fraction of other 
elements). The average interairspace wall distance (LM) was 
calculated from the formula LM = 2 X Z/number of transec- 
tions of septa within the 21 grid lines (or intercept number). 
The number of airspaces per unit area (NA) was determined 
by dividing the airspace number into the area of the counting 
grid. Airspace number per unit volume (NV) was calculated 
from the formula Nv = K(NA)3’2/p(Vvalv)1’2, where K is the 
 at M
edical Library, Erasm
us M
C on Decem
ber 13, 2012
http://ajplung.physiology.org/
D
ow
nloaded from
 
PRENATAL HORMONAL MODULATION IN CDH LlO61 
Table 1. Mean birth weights in newborn rats with and 
without CDH followingprenatal hormonal modulation 
Sham 4.55 + 0.11* 16 5.19 + 0.06* 24 
Dex 3.80 5 0.07”r 40 4.43 2 0.09 16 
Dex + TRH 3.62 t 0.03 47 4.63 t 0.09 25 
Values are means + SE; n, no. of animals per group; Dex, 
dexamethasone given intraperitoneally 72 and 48 h before delivery; 
Dex + TRH, addition of thyrotropin-releasing hormone (TRH) intra- 
peritoneally during 48 h before delivery. *Significantly higher than 
all other prenatal treatments in the same group (P < 0.001). t Signifi- 
cantly higher than Dex + TRH in the congenital diaphragmatic 
hernia (CDH) group (P < 0.05). 
coefficient size distribution constant (taken to be 1) and p = 
1.55, from the Weibel and Gomez shape constant (29). Total 
number of airspaces (NAT), total internal surface area (SA), 
and average airspace volume (AAV) were estimated from the 
following formulas: N AT = WVWLMA= 407~W~~d~b1,and 
finally MV = (Vv&(VL)lNAT. 
Radial saccular counts, a measure of the complexity of the 
respiratory acinus, were determined by counting the number 
of airspaces lying on a line drawn perpendicularly from the 
center of a terminal or respiratory bronchiole to the closest 
edge of the acinus (pleural or lobular connective tissue 
septum) (8). 
Data analysis. All data are presented as means 2 SE 
unless stated otherwise. Because data were normally distrib- 
uted, differences among the groups were tested by two-way 
analysis of variance and one-way analysis of variance with 
the Student-Newman-Keuls and Bonferroni-Dunn tests. x2 
Tests were used for proportions. Statistical significance was 
assumed at the 5% level. 
RESULTS 
In both CDH and controls, prenatal hormonal modu- 
lation resulted in lower birth weights compared with 
sham-treated pups (Table 1; P < 0.001). At birth, CDH 
rat pups had lower lung-to-body weight ratios than 
controls (Table 2; P < O.OOl), but hormonal modulation 
did not alter these ratios. The protein-to-DNA ratios 
were not different between the study groups (Table 2). 
In controls, prenatal hormonal treatment with the 
combination of Dex and TRH led to a significantly lower 
activity of glutathione reductase (P < 0.001) and to a 
higher activity of glutathione peroxidase (P = 0.002); 
the activities of catalase and SOD were not impaired 
(Fig. 1). In CDH, only the activity of glutathione 
reductase was significantly lower in the Dex + TRH 
Table 2. Lung-to-body weight ratios and lung 
protein-to-DNA ratios in newborn rats with and 
without CDH at birth 
Sham 
Dex 
Dex + TRH 
Lung-to-Body Weight 
Ratio, mg/g 
CDH Control 
15.9 + 0.8 26.6 IL 1.3* 
13.8 -+ 0.7 28.5 + 0.5* 
16.7 + 1.1 28.2 +_ 0.6* 
Protein-to-DNA 
Ratio, pg/pg 
CDH Control 
4.5 t 0.2 4.5 k 0.1 
4.6 2 0.1 4.9 t 0.2 
4.6 t 0.3 4.8 t 0.2 
Values are means + SE; n = 6 in the Dex-CDH group, n = 5 in all 
other groups. * Significantly different from CDH, same treatment; 
P < 0.001. 
group (P = 0.01). The activity of glutathione peroxidase 
did not increase as was the case in controls (Fig. 1). 
Prenatal treatment with Dex alone led to a higher 
activity of glutathione peroxidase and catalase in con- 
trols (P = 0.002 and P = 0.03, respectively). A similar 
trend to a higher activity of glutathione peroxidase and 
catalase was present in CDH, but these differences did 
not reach the level of significance. 
Intubation was successful in 50-70% of control rats 
irrespective of prenatal hormonal treatment. In the 
CDH rat pups, intubation was successful in 70% (7 of 
10) of the sham group; this was 26 (9 of 34) and 28% (12 
of 43) in the Dex and Dex + TRH groups, respectively 
(P < 0.01). Birth weights from rat pups that could not 
be intubated successfully did not differ from those that 
could be intubated (data not shown). The mortality rate 
or the incidence of pneumothorax were not significantly 
influenced by prenatal hormonal modulation (Fig. 2). 
Lung morphometry of CDH rat pups showed a signifi- 
cant increase of the AAV with a decrease in the number 
of airspaces in the Dex group compared with sham- 
CDH group (Table 3). The total internal SA was un- 
changed. These significant effects were stronger in the 
Dex + TRH group (Table 3). Representative pictures 
showing the effects of prenatal hormonal modulation on 
lung histology after artificial ventilation in CDH are 
shown in Fig. 3; there was no evidence of septal 
disruption or diffuse alveolar damage in any of the 
treatment groups. 
DISCUSSION 
In this study, we evaluated the effects of prenatal 
hormonal treatment on a number of parameters in a rat 
model of CDH. The major findings after artificial 
ventilation were that the survival rate was not influ- 
enced by hormonal therapy and that an increase in 
airspace volume without changes in the total internal 
SA was observed after prenatal Dex, with stronger 
effects after the addition of TRH. In addition, it is 
noteworthy that prenatal Dex + TRH resulted in 
decreased glutathione reductase activity in CDH rat 
pups and controls at birth. Hormonal treatment led to a 
significantly higher glutathione peroxidase activity in 
controls but not in CDH. 
In the present study, we confirmed the finding that 
prenatal hormonal modulation reduces birth weight, 
both in healthy full-term rats and in CDH rats (9, 13, 
14, 18, 24), and found no effect on lung-to-body weight 
ratios and lung protein-to-DNA ratios. That prenatal 
hormonal therapy has no effect on lung-to-body weight 
ratios and protein-to-DNA ratios suggests that lung 
growth is reduced to the same extent as body weight, 
which is in agreement with earlier studies (9,13). 
The effects of prenatal hormonal therapy on antioxi- 
dant enzyme activity at birth have previously been 
studied in full-term spontaneously born healthy rats (9, 
13, 18). Prenatal Dex administered 48 and 24 h before 
the expected time of delivery did not change the 
activities of catalase, glutathione peroxidase, and SOD 
(9, 13). We found that in control pups the activities of 
catalase and glutathione peroxidase increased signifi- 
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1. 1 .  Fig. 1. Antioxidant enzyme activity after birth in lungs of newborn rats with congenital diaphragmatic nerma 
(CDH) after prenatal hormonal modulation. All data are expressed as IU/mg DNA (mean and SE). Five to six 
animals per group were studied. Filled bar, sham treatment; hatched bar, dexamethasone (Dex) treatment; open 
bar, Dex + thyrotropin-releasing hormone (TRH) treatment. A: glutathione reductase. B: glutathione peroxidase. C: 
catalase. D: superoxide dismutase. *Significant difference compared with all other treatments in the same group, 
P < 0.05. ** Significant difference compared with the same treatment in controls, P < 0.05. 
cantly after prenatal treatment with Dex 72 and 48 h combination with TRH on the activities of catalase, 
before delivery by caesarean section. Our timing and glutathione peroxidase, and SOD compared with sham- 
dosage of Dex administration, which was based on a treated rat pups. Our observation that only the activity 
previous experiment in rat pups with CDH (24), may of glutathione reductase decreased after prenatal Dex + 
probably explain the differences compared with other TRH is not in accordance with their findings. The 
studies. dosage and timing of TRH was similar in both studies, 
Rodriquez and co-workers (18) reported, in full-term and it is not clear whether the difference in Dex 
normal rats, a negative effect of prenatal Dex in administration may explain the dissimilarity. However, 
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PRENATAL HORMONAL MODULATION IN CDH L1063 
A Lung morphometry showed higher AAV in Dex- 
sham (n=8) wwi 
treated and Dex + TRH-treated CDH pups than in the 
sham-CDH group, which is in accordance with previous 
findings in nonventilated CDH rats (24). Artificial 
ventilation may explain that the AAV in the present 
DEX (n=9) 71 study was three times higher than that in lungs of 
nonventilated pups (24). In neonatal rats and lambs 
with CDH, prenatal treatment with glucocorticoids 
DEX+TRH (n=12) wwi 
B 
sham (n=9) WI 
DEX (n=6) v/A 1 
significantly improved lung compliance (14, 21). The 
addition of TRH to Dex further improved alveolar 
stability and lung morphology in nonventilated rat 
pups with CDH (14). The increased lung compliance 
may result in an easier dilatation of airspaces and thus 
explain the observed higher AAV. That we did not 
observe evidence of septal disruption or diffuse alveolar 
damage suggests that prenatal hormonal therapy has 
beneficial effects on lung expansion that may have 
implications for the treatment of CDH patients: PIP 
may be lowered as soon as the lungs have been inflated 
properly, thus reducing the risk of volutrauma. 
DEX+TRH (n=ll) v/A 1 
0% 25% 50% 75% 100% 
Fig. 2. Incidence of pneumothorax and mortality in ventilated rat 
pups with CDH (A) and controls (B) after prenatal hormonal modula- 
tion. Number of animals that died from pneumothorax (solid bars) or 
by other causes (hatched bars) and the survivors (open bars) after 4 h 
of ventilation are indicated for each group. No significant differences 
were found. Dex, dexamethasone given intraperitoneally 72 and 48 h 
before delivery. Dex + TRH, addition of TRH intraperitoneally 
during 48 h before delivery. 
both their study and ours showed negative effects of 
prenatal Dex in combination with TRH on antioxidant 
enzyme activity. A lower activity of glutathione reduc- 
tase may result in a lower production rate of reduced 
glutathione, which is the substrate for the reduction of 
organic peroxides and hydrogen peroxide catalyzed by 
glutathione peroxidase. Catalase can convert hydrogen 
peroxide to water but is not able to catalyze the 
reduction of organic peroxides. The decreased activity 
of glutathione reductase after prenatal treatment with 
Dex and TRH may thus result in accumulation of 
organic peroxides (17). 
In the present study, up to 75% of CDH pups in the 
groups with prenatal hormonal therapy died during the 
procedure of intubation. This may be due to their low 
birth weights and not to structural changes induced by 
prenatal hormonal therapy, because controls, which all 
had a birth weight of >4 g, could be intubated easily 
irrespective of the prenatal hormonal therapy. Al- 
though the number of ventilated newborns studied was 
small, the results of the present study indicate that 
prenatal glucocorticoids and TRH did not affect the 
mortality rate or incidence of pneumothorax. Previous 
studies in full-term healthy rat pups exposed to hyper- 
oxia showed that Dex improves survival (9), whereas 
TRH or the combination of Dex and TRH has a negative 
effect on the survival rate (19). However, these effects in 
nonventilated rat pups were observed after at least 
1 wk. 
The VValv and the total internal SA did not change 
after prenatal hormonal therapy as a result of a lower 
NAT in the Dex-treated and Dex + TRH-treated CDH 
rats. The unchanged internal SA together with the 
increase in Vvalv is consistent with the premise that 
prenatal hormonal therapy accelerates lung matura- 
tion but not lung growth (24). Larger airspaces with a 
decreased number of alveoli have been found in prema- 
ture rhesus monkey fetuses after prenatal treatment 
with betamethasone (3). In addition, a similar finding 
has been ascribed to inhibited septation in rats at the 
age of 28 days after exposure to hyperoxia in combina- 
tion with postnatal Dex administration (4). Because 
septation in the rat starts around the third or fourth 
Table 3. Morphometric analysis of lungs after 4 h of 
artificial ventilation in newborn rats with CDH. Effect 
of prenatal hormonal modulation 
Sham Dex Dex + TRH 
Volume fraction of 
airspaces 0.63t0.01 0.6lkO.02 0.62t0.01 
Volume fraction of 
airspace walls 0.093~0.003 0.113~0.007* 0.125~0.007j- 
Volume fraction of 
airways 0.089 + 0.009 0.123 5 0.012* 0.142 + O.Oll-/- 
Volume fraction of 
other elements 0.187 + 0.009 0.156 + 0.008* 0.118 + 0.009$+ 
Average airspace 
volume, pm3 X lo5 3.06kO.12 4.53+0.30-f 5.74-+0.48+§ 
Total no. of air- 
spaces, X lo5 4.8050.16 3.31-+0.14$ 2.81kO.293: 
No. of airspaces/unit 
volume, prnM3 2.11 t 0.07 1.45 + 0.06$ 1.23 t 0.12$ 
Total internal sur- 
face area, 
pm2 X lOlo 3.6020.21 3.7lkO.20 3.7320.17 
Interairspace dis- 
tance, pm 16.8 + 0.75 16.12 0.98 15.4 + 0.60 
Radial saccular 
count 4.45t0.12 4.06r0.08-f 4.45+0.08$ 
Values are means + SE; n = 7 for Sham group, n = 9 for Dex group, 
and n = 5 for Dex-TRH group. *P < 0.05; "fP < 0.002; $P = 0.0001 
compared with sham-treated CDH; §P 5 0.01 compared with Dex- 
treated CDH by the Bonferroni-Dunn test. 
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Fig. 3. Representative pictures from lungs of CDH rats after 4 h of 
artificial ventilation. Lungs were inflated at a constant pressure of 20 
cmHz0 with 10% Formalin. A: sham-treated CDH. B: Dex-treated 
CDH. C: Dex + TRH-treated CDH. Magnification X200. 
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PRENATAL HORMONAL MODULATION IN CDH L1065 
postnatal day (5), it seems unlikely that inhibited 
septation explains the present findings. 
In conclusion, prenatal Dex had a positive effect on 13* 
the AN in ventilated newborn rats with CDH, and only 
a small synergistic effect was observed after the addi- 
tion of TRH. However, the activity of glutathione 14. 
reductase decreased significantly after prenatal treat- 
ment with Dex and TRH. We speculate that our find- 
ings of hormonal therapy in rat pups extend to CDH 
patients as well. If that hypothesis is correct, antenatal 
l5 
’ 
administration of Dex as a monotherapy will offer 
better prospects for randomized trials in prenatally 
diagnosed children with CDH than the combination of 16. 
Dex and TRH. 
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